04:15 AM EDT, 03/27/2026 (MT Newswires) -- Robert Barrow, Director, Chief Executive Officer, on March 25, 2026, sold 24,431 shares in Definium Therapeutics ( DFTX ) for $451,241. Following the Form 4 filing with the SEC, Barrow has control over a total of 752,454 common shares of the company, with 752,454 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1813814/000119312526126825/xslF345X05/ownership.xml